Effects of Psychotherapy on Quality of Life among Patients with Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis
Main Article Content
Abstract
Individuals diagnosed with inflammatory bowel disease (IBD) have been known to have diminished quality of life (QoL). This present study aimed to examine the impact of psychotherapy on the QoL of patients with IBD. A systematic search for studies was conducted through a total of six databases, namely, MEDLINE, PubMed, Scopus, SAGE, ProQuest (psychology database), and ProQuest (public health database) from their date of inception up to 20 March 2024. The inclusion criteria were studies on patients with IBD, carried out through a randomised controlled trial design, published in the English language, and with full-text content available online. Two researchers independently extracted articles that met the selection criteria and evaluated the quality of each study. A random-effects meta-analysis was conducted, and data were presented in weighted mean difference (WMD) with a 95% CI. Fourteen studies were included in the systematic review, of which three were included in the meta-analysis. Overall, while psychotherapy showed no significant improvements in some QoL domains such as clinical bowel condition and systemic symptoms, notable enhancements were observed in social functioning and overall QoL. The findings underscore the importance of integrating psychotherapeutic approaches into IBD management to address psychological and social challenges, thereby enhancing overall patient well-being. These results have significant implications for clinical mental health counsellors and future research in IBD care.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365(18):1713–1725. https://doi.org/10.1056/NEJMra1102942
Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2018;4(4):CD000542. https://doi.org/10.1002/14651858.CD000542.pub3
Gracie DJ, Hamlin PJ, Ford AC. The influence of the brain–gut axis in inflammatory bowel disease and possible implications for treatment. Lancet Gastroenterol Hepatol. 2019;4(8):632–642. https://doi.org/10.1016/S2468-1253(19)30089-5
Parra RS, Chebli JMF, Amarante H, Flores C, Parente JML, Ramos O, et al. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil. World J Gastroenterol. 2019;25(38):5862–5882. https://doi.org/10.3748/wjg.v25.i38.5862
Kolovos S, Kleiboer A, Cuijpers P. Effect of psychotherapy for depression on quality of life: meta-analysis. Br J Psychiatry. 2016;209(6):460–468. https://doi.org/10.1192/bjp.bp.115.175059
Irvine EJ. Quality of life of patients with ulcerative colitis: past, present, and future. Inflamm Bowel Dis. 2008;14(4):554–565. https://doi.org/10.1002/ibd.20301
Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses—part I. Inflamm Bowel Dis. 2018;24(4):742–751. https://doi.org/10.1093/ibd/izx100
Matos R, Lencastre L, Rocha V, Torres S, Vieira F, Barbosa MR, et al. Quality of life in patients with inflammatory bowel disease: the role of positive psychological factors. Health Psychol Behav Med. 2021;9(1):989–1005. https://doi.org/10.1080/21642850.2021.2007098
Mikocka-Walus A, Pittet V, Rossel JB, von Känel R. Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2016;14(6):829–835.e1. https://doi.org/10.1016/j.cgh.2015.12.045
Phang K, Abdul Latif AAL, Lee KW, Ching SM, Ooi PB. Effects of psychotherapy on quality of life in end-stage renal disease patients: a systematic review with meta-analysis. Oman Med J. 2022;37(3):e383. https://doi.org/10.5001/omj.2021.88
Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: scoping review. SAGE Open Med. 2016;4:2050312116671725. https://doi.org/10.1177/2050312116671725
König HH, Ulshöfer A, Gregor M, von Tirpitz C, Reinshagen M, Adler G, et al. Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002;14(11):1205–1215. https://doi.org/10.1097/00042737-200211000-00008
Sexton KA, Walker JR, Targownik LE, Graff LA, Haviva C, Beatie BE, et al. The inflammatory bowel disease symptom inventory: a patient-report scale for research and clinical application. Inflamm Bowel Dis. 2019;25(8):1277–1290. https://doi.org/10.1093/ibd/izz038
Cheung WY, Garratt AM, Russell IT, Williams JG. The UK IBDQ—a British version of the inflammatory bowel disease questionnaire: development and validation. J Clin Epidemiol. 2000;53(3):297–306. https://doi.org/10.1016/S0895-4356(99)00152-3
van Straten A, Geraedts A, Verdonck-de Leeuw I, Andersson G, Cuijpers P. Psychological treatment of depressive symptoms in patients with medical disorders: a meta-analysis. J Psychosom Res. 2010;69(1):23–32. https://doi.org/10.1016/j.jpsychores.2010.01.019
Segal ZV, Dimidjian S, Beck A, Boggs JM, Vanderkruik R, Metcalf CA, et al. Outcomes of online mindfulness-based cognitive therapy for patients with residual depressive symptoms: a randomized clinical trial. JAMA Psychiatry. 2020;77(6):563–573. https://doi.org/10.1001/jamapsychiatry.2019.4693
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–e34. https://doi.org/10.1016/j.jclinepi.2009.06.006
Review Manager (RevMan) [computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014.
Suurmond R, van Rhee H, Hak T. Introduction, comparison, and validation of Meta-Essentials: a free and simple tool for meta-analysis. Res Synth Methods. 2017;8(4):537–553. https://doi.org/10.1002/jrsm.1260
Barker TH, Stone JC, Sears K, Klugar M, Leonardi-Bee J, Tufanaru C, et al. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evid Synth. 2023;21(3):478–493. https://doi.org/10.11124/JBIES-22-00125
Bennebroek Evertsz F, Sprangers MAG, Sitnikova K, Stokkers PCF, Ponsioen CY, Bartelsman J, et al. Effectiveness of cognitive-behavioral therapy on quality of life, anxiety, and depressive symptoms among patients with inflammatory bowel disease: a multicenter randomized controlled trial. J Consult Clin Psychol. 2017;85(9):918–925. https://doi.org/10.1037/ccp0000227
Bredero QM, Fleer J, Smink A, Kuiken G, Potjewijd J, Laroy M, et al. Mindfulness-based cognitive therapy for fatigue in patients with inflammatory bowel disease: results of a randomized controlled trial. Mindfulness (NY). 2023;14(1):19–32. https://doi.org/10.1007/s12671-022-02057-5
Elsenbruch S, Langhorst J, Popkirowa K, Müller T, Luedtke R, Franken U, et al. Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom. 2005;74(5):277–287. https://doi.org/10.1159/000086318
Artom M, Czuber-Dochan W, Sturt J, Proudfoot H, Roberts D, Norton C. Cognitive-behavioural therapy for the management of inflammatory bowel disease–fatigue: a feasibility randomized controlled trial. Pilot Feasibility Stud. 2019;5:145. https://doi.org/10.1186/s40814-019-0538-y
Berrill JW, Sadlier M, Hood K, Green JT. Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels. J Crohns Colitis. 2014;8(9):945–955. https://doi.org/10.1016/j.crohns.2014.01.018
Mikocka-Walus A, Bampton P, Hetzel D, Hughes P, Esterman A, Andrews JM. Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomized controlled trial. BMC Gastroenterol. 2015;15:54. https://doi.org/10.1186/s12876-015-0278-2
Mikocka-Walus A, Bampton P, Hetzel D, Hughes P, Esterman A, Andrews JM. Cognitive-behavioural therapy for inflammatory bowel disease: 24-month data from a randomised controlled trial. Int J Behav Med. 2017;24(1):127–135. https://doi.org/10.1007/s12529-016-9580-9
Acciari A, Leão F, Coy C, Leal R, Dias C, Ayrizono M, et al. Effects of transpersonal brief psychotherapy on general state of health and life quality of patients with Crohn’s disease. J Coloproctol. 2015;35(3):162–167. https://doi.org/10.1016/j.jcol.2015.06.001
Bernabeu P, van-der Hofstadt C, Rodríguez-Marín J, Gutierrez A, Alonso MR, Zapater P, et al. Effectiveness of a multicomponent group psychological intervention program in patients with inflammatory bowel disease: a randomized trial. Int J Environ Res Public Health. 2021;18(10):5439. https://doi.org/10.3390/ijerph18105439
Boye B, Lundin KE, Jantschek G, Leganger S, Mokleby K, Tangen T, et al. INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn’s disease? A randomized controlled trial. Inflamm Bowel Dis. 2011;17(9):1863–1873. https://doi.org/10.1002/ibd.21575
Levy RL, van Tilburg MA, Langer SL, Romano JM, Walker LS, Mancl LA, et al. Effects of a cognitive behavioral therapy intervention trial to improve disease outcomes in children with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(9):2134–2148. https://doi.org/10.1097/MIB.0000000000000881
McCombie A, Gearry R, Andrews J, Mulder R, Mikocka-Walus A. Does computerized cognitive behavioral therapy help people with inflammatory bowel disease? A randomized controlled trial. Inflamm Bowel Dis. 2016;22(1):171–181. https://doi.org/10.1097/MIB.0000000000000567
Schoultz M, Atherton I, Watson A. Mindfulness-based cognitive therapy for inflammatory bowel disease patients: findings from an exploratory pilot randomized controlled trial. Trials. 2015;16(1):379. https://doi.org/10.1186/s13063-015-0909-5
Trindade IA, Pereira J, Galhardo A, Ferreira NB, Lucena-Santos P, Carvalho SA, et al. The LIFEwithIBD intervention: study protocol for a randomized controlled trial of a face-to-face acceptance and commitment therapy and compassion-based intervention tailored to people with inflammatory bowel disease. Front Psychiatry. 2021;12:699367. https://doi.org/10.3389/fpsyt.2021.699367